Changing open heart surgery forever with Edwards Lifesciences CEO Michael Mussallem

Changing open heart surgery forever with Edwards Lifesciences CEO Michael Mussallem
DeviceTalks Podcast Network
Changing open heart surgery forever with Edwards Lifesciences CEO Michael Mussallem

Jun 06 2013 | 00:23:19

/
Episode • June 06, 2013 • 00:23:19

Hosted By

Kayleen Brown Tom Salemi

Show Notes

After a stellar 2010, Michael Mussallem, CEO of Edwards Lifesciences Corp., is feeling bullish on transcatheter heart valves and the future of the Irvine, Calif.-based cardiac device maker.

Previous Episode

Inside Abiomed and GI Dynamics with CEOs Mike Minogue and Stu Randle

Next Episode

How we made an artificial nervous system with Alfred Mann Foundation CEO David Hankin

Other Episodes

July 11, 2025

Can Sinaptica Slow Alzheimer’s Painful Decline; Heidi Dohse on patient-centered design

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi hears encouraging news from Ken Mariash, CEO of Sinaptica Therapeutics, a neuromodulation company...

Play

00:54:37

June 30, 2014

How the Medtronic/Covidien merger will change medtech| A discussion

Panel discussion recorded at June 24th DeviceTalks Minnesota event featuring Nadim Yared, Deb Rectenwald, Philip Ebeling.

Play

00:31:12

November 18, 2015

A medtech veteran takes on C.diff: Rebiotix CEO Lee Jones

Clostridium difficile or C. diff. is a growing crisis in the U.S. with over 29,000 deaths and 500,000 cases annually, according to the CDC....

Play

00:20:53